Fundraising Fox
🦊/People
Sign in

Melissa Lokugamage

Investor

Strategic Leadership Program at AbbVie

Chicago, Illinois, United States

Find your path to Melissa

448 people in our graph share verified history with Melissa — schools, employers, funds. One of them is your warm intro.

Brando De CourtenunlockedMelissa: together at Georgia Institute of Technology (2017–2021)
×8Melissa: together at University of Missouri-Columbia
×2Melissa: together at AbbVie
Melissa: together at National Science Foundation

About

Melissa Lokugamage is a participant in AbbVie's Strategic Leadership Program and is involved in building new companies at 82VS. She holds a Ph.D. in Biomedical Engineering from Georgia Tech, with research focusing on non-hepatic delivery of lipid nanoparticles, nucleic acids, nanomedicine, and non-viral delivery modalities.

Experience

  1. AbbVieStrategic Leadership Programcurrent2026 — presentChicago, IL
  2. 82VSVenture Principal2025 — 2026Boston, MA
  3. 82VSSenior Venture Associate2023 — 2025Boston, Massachusetts, United States
  4. 82VSVenture Associate2021 — 2023Boston, Massachusetts
  5. Aakha BiologicsBoard Observer2023 — 2026Dallas, TX
  6. Ypsilon TherapeuticsBoard Observer2022 — 2026Houston, TX
  7. Ypsilon TherapeuticsHead of Corporate Development & Operations2022 — 2026Houston, TX
  8. Alloy Therapeutics, Inc.82VS, Venture Studio of Alloy Therapeutics2021 — 2026Boston, MA
  9. Georgia Institute of TechnologyGraduate Research Assistant2017 — 2021Atlanta, Georgia
  10. University of Missouri-ColumbiaUndergraduate Research Assistant2014 — 2017Columbia, Missouri
  11. NASA Ames Research CenterSpace Life Science Traning Program Intern2016Mountain View, California
  12. University of Missouri Success CenterMath Tutor2014 — 2016Columbia, MO
  13. National Science Foundation (NSF)NSF Undergraduate Research Fellow2013 — 2014University of Missouri

Skills & more

Research10Time Management6Biomedical Engineering2Molecular Biology2BiotechnologyPresentation Skills1Community Outreach1BioengineeringCRISPR/Cas9Gene EditingDrug DeliveryNanomedicine
+12 moreSystems BiologyDNA SequencingAnimal WorkAnimal HandlingCell BiologyLife SciencesMicrosoft OfficeMatlabTeamworkCritical ThinkingOrganization SkillsCommunication
  • VC University — VC University

From Melissa's professional profile.

Colleagues at AbbVie

Anke Reichardt
Investor at AbbVie
Azurii Collier
Commercial Advisor at 2Flo Ventures
Christian Schubert
Head of AbbVie Ventures at AbbVie
Christina Vorvis
Director at AbbVie
Claire Leurent
Managing Director at AbbVie
Donmienne Leung
Director II, Head of AbbVie Ventures Europe at AbbVie
Doug Faunce
Executive Director at AbbVie
Joachim Vogt
Director at AbbVie

Frequently asked questions

Who is Melissa Lokugamage?
Melissa Lokugamage is a participant in AbbVie's Strategic Leadership Program and is involved in building new companies at 82VS. She holds a Ph.D. in Biomedical Engineering from Georgia Tech, with research focusing on non-hepatic delivery of lipid nanoparticles, nucleic acids, nanomedicine, and non-viral delivery modalities.
Where does Melissa Lokugamage work?
Melissa Lokugamage is Strategic Leadership Program at AbbVie.
Where did Melissa Lokugamage go to school?
Melissa Lokugamage studied at Georgia Institute of Technology (Doctor of Philosophy, Biomedical Engineering); University of Missouri-Columbia (Bachelors of Science, Bioengineering).

Same school

Shared employers